American Conference Institute (ACI) will be holding its 11th Advanced Forum on Biotech Patents on September 30 to October 1, 2009 in Boston, MA. The conference will allow attendees to:
• Adopt a practical approach to incorporating follow-on biologics into your current patent strategies;
• Implement best practices for avoiding § 112 and § 103 rejections in light of Kubin, Ariad, and KSR for patenting biotech inventions including gene sequences;
• Establish effective strategies to overcome charges of inequitable conduct;
• Uncover ways to overcome increasing rejections related to diagnostic and treatment claims and integrate Bilski and related precedents into current strategies;
• Design global patent strategies that take into account developing standards abroad and patent harmonization efforts;
• Identify and utilize key European patent litigation strategies; and
• Optimize freedom to operate assessments.
In particular, ACI's faculty will offer presentations on the following topics:
• Preparing for the inevitable enactment of follow-on biologics legislation and adopting a practical approach to integrating FOB's into your patent strategies;
• Politics and patents: Reassessing your patent strategy in light of current changes;
• Uncovering current trends and predicting future changes facing biotech patent practitioners;
• What's patentable? The impact of Bilski and related precedents to diagnostic testing and treatment claims in the biotech patent industry -- to be presented in part by Patent Docs author Kevin Noonan;
• Deciphering the impact of In re Kubin on application of § 103 obviousness requirements;
• Strategies for patenting biotechnology inventions with evolving § 112 jurisprudence;
• Cultivating proactive prosecution strategies to overcome charges of inequitable conduct;
• Developing global biotech patent strategies and indentifying key rule changes in foreign patent offices;
• Spotlight presentation: European biotech patent law;
• Tactics for breaking through the challenges associated with antibody patent prosecution; and
• Freedom to operate assessments for the biotech industry.
An additional master class entitled: "Drafting Successful Patent Applications for Biotechnology Inventions" will be offered on October 2, 2008. The master class will provide attendees with the tools they need to draft strong applications that will be well positioned to withstand future challenges.
The agenda for the Biotech Patents conference can be found here. A complete brochure for this conference, including an agenda, list of speakers, and registration form can be obtained here.
The registration fee ranges from $2,195 (conference) to $2,795 (conference plus master class). Those registering on or before August 21, 2009 will receive a $200 discount. ACI will provide a $400 discount off the standard price to all Patent Docs readers who reference the discount code "MBHB" when registering. Those interested in registering for the conference can do so here, by calling 1-888-224-2480, or by faxing a registration form to 1-877-927-1563.
Patent Docs is a media partner of ACI's Biotech Patents conference.
Comments